Skip to search boxSkip to navigationSkip to main content

Development of trochlear motor neurons, superior oblique muscle, and neuromuscular junctions following prevention of cell death by myasthenia gravis immunoglobulin

  • G. S. Sohal(corresponding author)
    ,
  • T. R. Swift
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Paralysis of embryo during the period of naturally occurring motor neuron death produces an increase in the number of surviving neurons while the progressive differentiation and maturation of target muscle is severely retarded. Application of immunoglobulin G from patients with acquired myasthenia gravis to duck embryos during the period of trochlear motor neuron death also prevents this neuron loss but without paralyzing the embryo. The present study was conducted to investigate whether or not the differentiation and maturation of motor neurons, target muscle, and neuromuscular junctions were retarded following prevention of cell loss with myasthenic immunoglobulin. Immunoglobulin concentrates from myasthenics and normal human volunteers were applied daily to the chorioallantoic membrane of duck embryos from day 10 onward. The development of the trochlear neurons and the superior oblique muscle was examined with light and electron microscopy on embryonic days 12, 16 and 20. The motor neurons at the light and electron microscopic level were cytologically indistinguishable between the myasthenic and normal immunoglobulin-treated embryos. Myoblasts fused to form myotubes. which further differentiated into mature myofibers at the same time in both groups. Numerous neuromuscular junctions of normal ultrastructure and nerve fibers with myelin wrappings were observed in both cases. It is concluded that the increased neuron survival following myasthenic immunoglobulin treatment does not accompany retardation in differentiation and maturation of the target muscle which is contrary to the results obtained from studies utilizing neuromuscular blocking agents producing increased cell survival.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 573-582 (10 pages)

Journal (Volume, Issue Number)

International Journal of Developmental Neuroscience (Volume 3, Issue 5)

Publication milestones

  • Published - 1985

Publication status

Published - 1985

ISSN

0736-5748

Publication IDs

  • Scopus: 0022179765

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
4
Captures
4

Funding Details

AcknowlrciKemenrs-This work was supported by NIH grants HD17800. HDIXZXO and by a grant from Muscular Dystrophy Association. We gratefully acknowledge the technical assistance of Teena Knox. Penny Roon and secretarial assistance of Lynn Morgan.
FundersFunding number
NIH
HD17800
MDA
-